გამოგვყევი
GE
GE

Life4me+-ის ერთ-ერთი მთავარი მიზანია აივ, სხვა სგგი, ჰეპატიტი C და ტუბერკულოზის ახალი შემთხვევების პრევენცია.

აპლიკაცია ეხმარება აივ დადებით პირებს ექიმებთან ანონიმური კომუნიკაციის დამყარებაში. ეს ყველაფერი დაგეხმარებათ ორგანიზება გაუკეთოთ მედიკამენტების მიღების განრიგს და დააყენოთ ფარული და პერსონალიზებული შეხსენებები.

ყველა სიახლე

არქივი

✕
9 თებერვალი 2018
5127
HIV prevention drug Truvada to be publicly funded in New Zealand

HIV prevention drug Truvada to be publicly funded in New Zealand

Pharmac estimates up to 4,000 people with a high risk of contracting HIV will be eligible for a drug to prevent infection with the virus which the Government's drug buying agency will now fund. New Zealand will be one of the first countries in the world to publicly fund ...
9 თებერვალი 2018
4980
Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole is stepping down as amfAR chairman, the designer announced Wednesday night at the charity's annual gala in New York.
9 თებერვალი 2018
5181
Ukraine Expands Opioid Substitution Therapy to Reduce HIV

Ukraine Expands Opioid Substitution Therapy to Reduce HIV

The Ukrainian government is increasing the scope of the country’s state-funded opioid substitution therapy programme – a harm reduction tool which reduces the risk of overdose and disease transmission.
8 თებერვალი 2018
4921
Scientists report big improvements in HIV vaccine production

Scientists report big improvements in HIV vaccine production

Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested.
8 თებერვალი 2018
7460
FDA Approves Gilead’s Biktarvy for Treatment of HIV

FDA Approves Gilead’s Biktarvy for Treatment of HIV

Food and Drug Administration has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen for the treatment of HIV-1 infection.
7 თებერვალი 2018
4781
New data helps prioritise groups for HIV treatment

New data helps prioritise groups for HIV treatment

People aged 50 or over, individuals with low CD4 to CD8 ratios, and those with high viral loads are the groups that benefit the most from immediate antiretroviral treatment.
7 თებერვალი 2018
5411
New insight into how some viruses establish a chronic infection

New insight into how some viruses establish a chronic infection

The previously undiscovered molecular mechanism explains how certain viruses, including HIV and hepatitis C, can actively make immune cells less functional, allowing an infection to spread ahead of the body's immune response.
6 თებერვალი 2018
7827
Persian shallot could help fight TB antibiotic resistance

Persian shallot could help fight TB antibiotic resistance

A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a study has suggested.
6 თებერვალი 2018
8323
Mobile app for free condoms launched in the Philippines

Mobile app for free condoms launched in the Philippines

To tackle low condom use, activists have teamed up with restaurants and shops to set up dispensers with free condoms in the capital Manila which users can locate through an app.
5 თებერვალი 2018
5575
Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

According to the study authors, HIV-infected hospitalized children initiating antiretroviral therapy are part of “a group in which tuberculosis diagnosis is often missed, and in whom early tuberculosis treatment is lifesaving.”
ჩვენ ვიყენებთ ქუქის, რათა გავაუმჯობესოთ თქვენ მიერ საიტის მოხმარება
ვებ-გვერდზე ნებისმიერ ღილაკზე დაჭერით თქვენ გვაძლევთ უფლებას, რომ გამოვიყენოთ თქვენი cookies.